Subscribe To
QGEN / Qiagen: Fantastic Growth At A Reasonable Price Pick
QGEN News
By Zacks Investment Research
October 31, 2023
QIAGEN (QGEN) Q3 Earnings and Revenues Beat, Margins Down
In an increasingly challenging macro environment, QIAGEN (QGEN) surpasses the earnings and revenue outlook in the third quarter of 2023. more_horizontal
By Zacks Investment Research
October 30, 2023
Qiagen (QGEN) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended September 2023, it might be worth consi more_horizontal
By Zacks Investment Research
October 30, 2023
Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates
Qiagen (QGEN) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings more_horizontal
By Zacks Investment Research
October 18, 2023
Here's Why You Should Retain QIAGEN (QGEN) Stock for Now
Investors are optimistic about QIAGEN's (QGEN) growth in the molecular diagnostics business and the latest acquisition. more_horizontal
By Zacks Investment Research
September 26, 2023
QIAGEN (QGEN) Extends QIAwave Product Line With New Kit
QIAGEN's (QGEN) new QIAwave kits broaden its selection of environmentally friendly products and reaffirm its commitment to helping researchers advance more_horizontal
By Seeking Alpha
August 9, 2023
Qiagen NV (QGEN) Q2 2023 Earnings Call Transcript
Qiagen NV (NYSE:QGEN ) Q2 2023 Earnings Conference Call August 9, 2023 9:00 AM ET Company Participants John Gilardi - VP, Corporate Communications & I more_horizontal
By Zacks Investment Research
August 9, 2023
QIAGEN (QGEN) Q2 Earnings and Revenues Top, '23 View Slashed
QIAGEN (QGEN) surpasses the earnings and revenue outlook in the second quarter of 2023 amid a challenging macro environment. more_horizontal
By Zacks Investment Research
August 8, 2023
Qiagen (QGEN) Surpasses Q2 Earnings and Revenue Estimates
Qiagen (QGEN) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.50 per share. This compares to earnings more_horizontal